GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vaishali Pharma Ltd (NSE:VAISHALI) » Definitions » PEG Ratio

Vaishali Pharma (NSE:VAISHALI) PEG Ratio : 3.98 (As of Sep. 23, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Vaishali Pharma PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Vaishali Pharma's PE Ratio without NRI is 50.17. Vaishali Pharma's 5-Year EBITDA growth rate is 12.60%. Therefore, Vaishali Pharma's PEG Ratio for today is 3.98.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Vaishali Pharma's PEG Ratio or its related term are showing as below:

NSE:VAISHALI' s PEG Ratio Range Over the Past 10 Years
Min: 1.01   Med: 2.65   Max: 3.98
Current: 3.98


During the past 12 years, Vaishali Pharma's highest PEG Ratio was 3.98. The lowest was 1.01. And the median was 2.65.


NSE:VAISHALI's PEG Ratio is ranked worse than
78.65% of 370 companies
in the Drug Manufacturers industry
Industry Median: 1.675 vs NSE:VAISHALI: 3.98

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Vaishali Pharma PEG Ratio Historical Data

The historical data trend for Vaishali Pharma's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaishali Pharma PEG Ratio Chart

Vaishali Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 2.19 1.17 2.55

Vaishali Pharma Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 2.55 -

Competitive Comparison of Vaishali Pharma's PEG Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Vaishali Pharma's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaishali Pharma's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vaishali Pharma's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Vaishali Pharma's PEG Ratio falls into.



Vaishali Pharma PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Vaishali Pharma's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=50.171651495449/12.60
=3.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Vaishali Pharma  (NSE:VAISHALI) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Vaishali Pharma PEG Ratio Related Terms

Thank you for viewing the detailed overview of Vaishali Pharma's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaishali Pharma Business Description

Traded in Other Exchanges
N/A
Address
R.C. Patel Road, Off Sodawala Lane, 706-709, 7th Floor, Aravalli Business Center, Borivili (West), Mumbai, MH, IND, 400092
Vaishali Pharma Ltd is a pharmaceutical company. The company is engaged in the business of trading (including exports) pharmaceuticals products. It mainly deals in Active Pharmaceutical Ingredient, pharmaceutical formulations, surgical products, Herbal and Nutraceutical Products, and veterinary supplements operating in the domestic and export market.

Vaishali Pharma Headlines

No Headlines